China NMPA approves Ascletis’ IND for advanced solid tumours therapy
Clinical Trials
MEI and Kyowa Kirin to discontinue development of zandelisib outside Japan
Based on findings from the MIRAGE and TIDAL trials, Kyowa Kirin will seek marketing authorisation in Japan.
Emalex raises $250m for Tourette syndrome drug development
EC grants orphan status for Karyopharm-Menarini’s selinexor
Astellas to support development of Taysha’s gene therapy programmes
Oculis enters merger deal with European Biotech Acquisition
Vita Therapeutics raises funds for cell therapies development
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
